Mounjaro (Tirzepatide) KwikPen 15 mg / 4 Doses (8 weeks supply)

Mounjaro (Tirzepatide) KwikPen 15 mg / 4 Doses
Mounjaro is a modern injectable medication based on tirzepatide, designed for blood glucose control in patients with type 2 diabetes, and also used as part of weight management programs under medical supervision. The product is available in a convenient pre-filled KwikPen designed for 4 weeks of use.
Composition and form:
Each pen contains 4 doses of 15 mg tirzepatide (total 60 mg in 2.4 ml solution). The solution is clear, colorless or slightly yellowish, and ready to use without any preparation.
Mechanism of action:
Tirzepatide is an innovative dual GIP and GLP-1 receptor agonist. It helps to:
reduce blood glucose levels
improve insulin sensitivity
decrease appetite
support gradual weight loss
Directions for use:
Administer subcutaneously once weekly (in the abdomen, thigh, or upper arm). One pen is designed for 4 consecutive injections.
Indications:
Type 2 diabetes mellitus
Overweight and obesity (as prescribed by a healthcare professional)
Benefits:
convenient once-weekly dosing
effective glycemic control
additional weight loss support
easy self-administration
Possible side effects:
The most common include:
nausea
digestive disturbances
reduced appetite
fatigue
These effects are usually temporary and tend to decrease as the body adjusts.